# Sulforaphane Supplementation in Atopic Asthmatics

> **NCT01845493** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 16 (actual)

## Conditions studied

- Asthma

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha Sprout Homogenate
- **DIETARY_SUPPLEMENT:** Sulforaphane Homogenate

## Key facts

- **NCT ID:** NCT01845493
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845493, "Sulforaphane Supplementation in Atopic Asthmatics". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01845493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*